Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Ethereum’s Fusaka upgrade introduces PeerDAS, new blob economics and key UX improvements that push deeper into the Surge, ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

The HackerEarth platform itself is pretty standard for online coding tests. You’ll have a code editor where you write your ...

To arrive at a language late is to see it without the forgiving haze of sentimentality that comes with imprinting—the fond willingness to overlook a flaw as a quirk. What I saw ...

In a world of nonstop disruption, stability is a myth. Discover why leaders need a reinvention system—not one‑time fixes—to ...

Context helps AI interpret information instead of just processing it. When systems can connect data, history and intent, they ...

Researchers from Saarland University and the Max Planck Institute for Software Systems have, for the first time, shown that ...

Infectious diseases such as bacterial, viral, fungal and parasitic diseases continue to have a significant impact on global health. Hence, knowledge on how infection spread, population vulnerable to ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.